Skip to main content
Signal8

BERENDT MICHAEL J

SEC insider (Form 3/4/5 filer). CIK 0001186877. Director at Retension Pharmaceuticals, Inc. (RTSN). 3 reported Form 4/5 transactions since Sep 2024; latest on Oct 13, 2026. Located in FALLS CHURCH, VA.

Companies BERENDT MICHAEL J has filed insider reports for

  • Retension Pharmaceuticals, Inc. (RTSN): Director
BERENDT MICHAEL J profile photo

BERENDT MICHAEL J

CIK: 0001186877

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)2 (66.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Retension Pharmaceuticals, Inc. logo
RTSN

Retension Pharmaceuticals, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Retension Pharmaceuticals, Inc. logo
    RTSN

    Retension Pharmaceuticals, Inc.

    Oct 13, 2026
    Conversion
    Direct
    4K shares-
  • Retension Pharmaceuticals, Inc. logo
    RTSN

    Retension Pharmaceuticals, Inc.

    Oct 13, 2026
    Conversion
    Direct
    2.6K shares-
  • Retension Pharmaceuticals, Inc. logo
    RTSN

    Retension Pharmaceuticals, Inc.

    Oct 8, 2026
    Award

    Stock Option (right to buy)

    Direct
    5.6K shares-

1-3 of 3